High-throughput screening using siRNA (RNAi) libraries

Expert Review of Molecular Diagnostics

Volumn 7, Issue 3, 2007, Pages 281-291

  Chen, Meihong ^b,c   Du, Quan ^a   Zhang, Hong Yan ^d   Wang, Xiaoxia ^a   Liang, Zicai ^a  

^a PEKING UNIVERSITY   (China)

^b Department of Pharmacology   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

High content screening; High throughput screening; Libraries; RNA interference; RNAi; siRNA

Indexed keywords

DOUBLE STRANDED RNA; SMALL INTERFERING RNA; VIRUS VECTOR;

CAENORHABDITIS ELEGANS; DROSOPHILA; FUNCTIONAL GENOMICS; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PLASMID; REVIEW; RNA INTERFERENCE; TRYPANOSOMA;

ANIMALS; GENE LIBRARY; GENETIC TESTING; GENETIC VECTORS; GENOMICS; HUMANS; RNA, SMALL INTERFERING;

EID: 34249084388     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.7.3.281     Document Type: Review

References (85)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998). •• Milestone paper for RNA interference (RNAi) in which the gene-silencing phenomena was first elucidated.
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001). •• Milestone paper for RNAi in which small-interfering RNA (siRNA) was first discovered.
3. Tuschl T. RNA interference and small interfering RNAs. Chembiochem 2, 239-245 (2001).
4. Cullen BR. RNA interference: antiviral defense and genetic tool. Nat. Immunol. 3, 597-599 (2002).
5. St Johnston D. The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet. 3, 176-188 (2002).
6. Yamamura K. Overview of transgenic and gene knockout mice. Prog. Exp. Tumor Res. 35, 13-24 (1999).
7. Cazenave C, Loreau N, Thuong NT, Toulme JJ, Helene C. Enzymatic amplification of translation inhibition of rabbit β-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents. Nucleic Acids Res. 15, 4717-4736 (1987).
8. Opalinska JB, Gewirtz AM. Nucleic-acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discov. 1, 503-514 (2002).
9. Zhang HY, Mao J, Zhou D. mRNA Accessible Site Tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Res. 31, e72 (2003).
10. Lee NS, Dohjima T, Bauer G et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500-505 (2002).
11. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948-958 (2002).
12. Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nat. Blotechnol. 20, 1006-1010 (2002).
13. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 99, 6047-6052 (2002).
14. Sui G, Soohoo C, Affar el B et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA 99, 5515-5520 (2002).
15. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
16. Castanotto D, Li H, Rossi JJ. Functional siRNA expression from transfected PCR products. RNA 8, 1454-1460 (2002).
17. Abbas-Terki T, Blanco-Bose W, Deglon N, Pralong W, Aebischer R Lentiviral-mediated RNA interference. Hum. Gene. Ther. 13, 2197-2201 (2002).
18. Stewart SA, Dykxhoorn DM, Palliser D et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493-501 (2003).
19. Chen M, Zhang L, Zhang HY et al. A universal plasmid library encoding all permutations of small interfering RNA. Proc. Natl Acad. Sci. USA 102, 2356-2361 (2005).
20. Zheng L, Liu J, Batalov S et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 101, 135-140 (2004).
21. Barton GM, Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl Acad. Sci. USA 99, 14943-14945 (2002).
22. van de Wetering M, Oving I, Muncan V et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO. Rep. 4, 609-615 (2003).
23. Zeng Y, Wagner EJ, Cullen BR. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol.Cell. 9, 1327-1333 (2002).
24. Hosono T, Mizuguchi H, Katayama K et al. RNA interference of PPARy using fiber-modified adenovirus vector efficiently suppresses preadipocyte-to-adipocyte differentiation in 3T3-L1 cells. Gene 348, 157-165 (2005).
25. Li MJ, Bauer G, Michienzi A et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol. Ther. 8, 196-206 (2003).
26. Du C, Ge B, Liu Z, Fu K, Chan WC, McKeithan TW. PCR-based generation of shRNA libraries from cDNAs. BMC Blotechnol. 6, 28 (2006).
27. Seyhan AA, Vlassov AV, Ilves H et al. Complete, gene-specific siRNA libraries: production and expression in mammalian cells. RNA 11, 837-846 (2005).
28. Sen G, Wehrman TS, Myers JW, Blau HM. Restriction enzyme-generated siRNA (REGS) vectors and libraries. Nat. Genet. 36, 183-189 (2004).
29. Shirane D, Sugao K, Namiki S, Tanabe M, Iino M, Hirose K. Enzymatic production of RNAi libraries from cDNAs. Nat. Genet. 36, 190-196 (2004).
30. Luo B, Heard AD, Lodish HF. Small interfering RNA Production by Enzymatic Engineering of DNA (SPEED). Proc. Natl Acad. Sci. USA 101, 5494-5499 (2004).
31. Calegari F, Haubensak W, Yang D, Huttner WB, Buchholz F. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease- prepared short interfering RNA. Proc. Natl Acad. Sci. USA 99, 14236-14240 (2002).
32. Buchholz F, Kittler R, Slabicki M, Theis M. Enzymatically prepared RNAi libraries. Nat. Methods. 3, 696-700 (2006).
33. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325-330 (2000). •• High-throughput analysis of gene functions using siRNA library covering a substantial part of the genome in Caenorhabditis elegans.
34. Kamath RS, Fraser AG, Dong Y et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421, 231-237 (2003).
35. Boutros M, Kiger AA, Armknecht S et al. Heidelberg Fly Array Consortium. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303, 832-835 (2004).
36. Subramaniam C, Veazey P, Redmond S et al. Chromosome-wide analysis of gene function by RNA interference in the african trypanosome. Eukaryot. Cell. 5, 1539-1549 (2006).
37. Akashi H, Matsumoto S, Taira K. Gene discovery by ribozyme and siRNA libraries. Nat. Rev. Mol. Cell. Biol. 6, 413-422 (2005).
38. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378 (2004).
39. Ito M, Kawano K, Miyagishi M, Taira K. Genome-wide application of RNAi to the discovery of potential drug targets. FEBS Lett. 579, 5988-5995 (2005).
40. Liang Z. High-throughput screening using genome-wide siRNA libraries. Drugs 8, 924-926 (2005).
41. Sachse C, Krausz E, Kronke A et al. High-throughput RNA interference strategies for target discovery and validation by using synthetic short interfering RNAs: functional genomics investigations of biological pathways. Methods Enzymol. 392, 242-277 (2005).
42. Vanhecke D, Janitz M. Functional genomics using high-throughput RNA interference. Drug Discov. Today 10, 205-212 (2005).
43. Westbrook TF, Stegmeier F, Elledge SJ. Dissecting cancer pathways and vulnerabilities with RNAi. Cold Spring Harb. Symp. Quant. Biol. 70, 435-444 (2005).
44. Zhao HF, L'Abbe D, Jolicoeur N et al. High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion. Nat. Mediods. 2, 967-973 (2005).
45. Chang K, Elledge SJ, Hannon GJ. Lessons from nature: microRNA-based shRNA libraries. Nat. Methods. 3, 707-714 (2006).
46. Lents NH, Baldassare JJ. RNA interference takes flight: a new RNAi screen reveals cell cycle regulators in Drosophila cells. Trends Endocrinol. Metab. 17, 173-174 (2006).
47. Moffat J, Sabatini DM. Building mammalian signalling pathways with RNAi screens. Nat. Rev. Mol. Cell. Biol. 7, 177-187 (2006).
48. Root DE, Hacohen N, Hahn WC, Lander ES, Sabatini DM. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat. Methods. 3, 715-719 (2006).
49. Ngo VN, Davis RE, Lamy L et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106-110 (2006).
50. Friedman A, Perrimon N. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature 444, 230-234 (2006).
51. Muller P, Kuttenkeuler D, Gesellchen V, Zeidler MP, Boutros M. Identification of JAK/STAT signalling components by genome-wide RNA interference. Nature 436, 871-875 (2005).
52. Kiger B, Baum S, Jones MR et al. A functional genomic analysis of cell morphology using RNA interference. J. Biol. 2(4), 27 (2003).
53. Bettencourt-Dias M, Giet R, Sinka R et al. Genome-wide survey of protein kinases required for cell cycle progression. Nature 432, 980-987 (2004).
54. Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12, 627-637 (2003).
55. Pelkmans L, Fava E, Grabner H et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78-86 (2005).
56. Espeseth AS, Huang Q, Gates A et al. A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levels. Mol. Cell. Neurosci. 33, 227-235 (2006).
57. Kittler R, Putz G, Pelletier L et al. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 432, 1036-1040 (2004).
58. Berns K, Hijmans EM, Mullenders J et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431-437 (2004).
59. Llanos S, Efeyan A, Monsech J, Dominguez O, Serrano M. A high-throughput loss-of-function screening identifies novel p53 regulators. Cell Cycle 5, 1880-1885 (2006).
60. Paddison PJ, Silva JM, Conklin DS et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428, 427-431 (2004).
61. Westbrook TF, Martin ES, Schlabach MR et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 121, 837-848 (2005).
62. Silva JM, Li MZ, Chang K et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat. Genet. 37, 1281-1288 (2005). •• The hairpin-type siRNA expressed from this library was designed to mimic a natural microRNA primary transcript.
63. Mukherji M, Bell R, Supekova L et al. Genome-wide functional analysis of human cell-cycle regulators. Proc. Natl Acad. Sci. USA 103, 14819-14824 (2006).
64. Nguyen DG, Wolff KC, Yin H, Caldwell JS, Kuhen KL. "UnPAKing" human immunodeficiency virus (HIV) replication: using small interfering RNA screening to identify novel cofactors and elucidate the role of group I PAKs in HIV infection. J. Virol. 80, 130-137 (2006).
65. Moffat J, Grueneberg DA, Yang X et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298 (2006). •• Example of comprehensive high-content screening. The library was developed by The RNAi Consortium (TRC; a cluster of academic and industrial partners teamed together under the goal of generating genome-scale shRNA libraries in viral vectors.)
66. Kolfschoten IG, van Leeuwen B, Berns K et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 121, 849-858 (2005).
67. Brummelkamp TR, Fabius AW, Mullenders J et al. An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nat. Chem. Biol. 2, 202-206 (2006).
68. Collins CS, Hong J, Sapinoso L et al. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Proc. Natl Acad. Sci. USA 103, 3775-3780 (2006).
69. Bartz SR, Zhang Z, Burchard J et al. Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol. Cell. Biol. 26, 9377-9386 (2006).
70. Sonnichsen B, Koski LB, Walsh A et al. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature 434, 462-469 (2005).
71. Hamilton B, Dong Y, Shindo M et al. A systematic RNAi screen for longevity genes in C. elegans. Genes Dev. 19, 1544-1555 (2005).
72. Kambris Z, Brun S, Jang IH et al. Drosophila immunity: a large-scale in vivo RNAi screen identifies five serine proteases required for Toll activation. Curr. Biol. 16, 808-813 (2006). •• The only RNAi-based in vivo screening performed on species other than worms.
73. Saxena S, Jonsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 278, 44312-44319 (2003).
74. Jackson AL Linsley PS. Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 20, 521-524 (2004).
75. Ding H, Schwarz DS, Keene A et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2, 209-217 (2003).
76. Snove O Jr. Holen T Many commonly used siRNAs risk off-target activity. Biochem. Biophys. Res. Commun. 319, 256-263 (2004).
77. Jackson AL, Burchard J. Schelter J et al. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA 12, 1179-1187 (2006).
78. Chang FH, Lee CH, Chen MT et al. Surfection: a new platform for transfected cell arrays. Nucleic Acids Res. 32, e33 (2004).
79. Mousses S, Caplen NJ, Cornelison R et al. RNAi microarray analysis in cultured mammalian cells. Genome Res. 13, 2341-2347 (2003). •• One of the early proof of concepts for the application of reverse transfection in RNAi screening.
80. Erfle H, Simpson JC, Bastiaens PI, Pepperkok R. siRNA cell arrays for high-content screening microscopy. Blotechnlques 37, 454-462 (2004).
81. Vanhecke D, Janitz M. High-throughput gene silencing using cell arrays. Oncogene 23, 8353-8358 (2004).
82. Bailey SN, Ali SM, Carpenter AE, Higgins CO, Sabatini DMR. Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat. Methods 3, 117-122 (2006).
83. Sims D, Bursteinas B, Gao Q, Zvelebil M, Baum B. FLIGHT, database and tools for the integration and cross-correlation of large-scale RNAi phenotypic datasets. Nucleic Acids Res. 34, D479-D483 (2006). •• The database provided an initial platform for data integration of siRNA-based phenotypic screening.
84. Horn T, Arziman Z, Berger J, Boutros M. GenomeRNAi: a database for cell-based RNAi phenotypes. Nucleic Acids Res. 35, D492-D497 (2007).
85. Minimum information about an RNAi study http://miare.sourceforge.net/ HomePage